Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

MD To evaluate whether the presence of CIN 1 on ECC contributes to additional risk for CIN 2/3 compared with isolated ectocervical CIN 1, Petersen et al. [2] compared 37 women with low-grade ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical intraepithelial neoplasia grade 3 (CIN3), vaccination with a replication-incompetent Semliki Forest virus vaccine ...

Fifty percent of patients with CIN3 had histopathological complete response ... had a histopathological complete response (regression to CIN1 or no dysplasia) and 63% of patients had HPV16 ...